Atlas Trials

Hyperbaric Oxygen Therapy Improves Brain Function in Patients With Cognitive Decline After COVID-19 Infection.

Clinical trial NCT05715801 · UNKNOWN

Trial details

NCT number
NCT05715801
Sponsor
The First Affiliated Hospital of Zhejiang Chinese Medical University
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Cognitive DeclineCOVID-19SARS CoV 2 Infection
Start date
2023-01-29
Primary completion
2024-01-31
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.